Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 1
2004 2
2005 2
2006 5
2007 1
2008 6
2009 4
2010 5
2011 6
2012 5
2013 4
2014 3
2015 4
2016 7
2017 7
2018 6
2019 3
2020 4
2021 3
2022 8
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry.
Beck M, Ramaswami U, Hernberg-Ståhl E, Hughes DA, Kampmann C, Mehta AB, Nicholls K, Niu DM, Pintos-Morell G, Reisin R, West ML, Schenk J, Anagnostopoulou C, Botha J, Giugliani R. Beck M, et al. Among authors: kampmann c. Orphanet J Rare Dis. 2022 Jun 20;17(1):238. doi: 10.1186/s13023-022-02392-9. Orphanet J Rare Dis. 2022. PMID: 35725623 Free PMC article. Review.
An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis.
Wiesinger AM, Bigger B, Giugliani R, Lampe C, Scarpa M, Moser T, Kampmann C, Zimmermann G, Lagler FB. Wiesinger AM, et al. Among authors: kampmann c. Pharmaceutics. 2023 May 22;15(5):1565. doi: 10.3390/pharmaceutics15051565. Pharmaceutics. 2023. Retraction in: Pharmaceutics. 2023 Nov 07;15(11):2596. doi: 10.3390/pharmaceutics15112596. PMID: 37242808 Free PMC article. Retracted.
Cardiac involvement in Anderson-Fabry disease.
Kampmann C, Baehner F, Ries M, Beck M. Kampmann C, et al. J Am Soc Nephrol. 2002 Jun;13 Suppl 2:S147-9. J Am Soc Nephrol. 2002. PMID: 12068028 Review. No abstract available.
Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS).
Lenders M, Nordbeck P, Kurschat C, Eveslage M, Karabul N, Kaufeld J, Hennermann JB, Patten M, Cybulla M, Müntze J, Üçeyler N, Liu D, Das AM, Sommer C, Pogoda C, Reiermann S, Duning T, Gaedeke J, von Cossel K, Blaschke D, Brand SM, Mann WA, Kampmann C, Muschol N, Canaan-Kühl S, Brand E. Lenders M, et al. Among authors: kampmann c. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):272-281. doi: 10.1093/ehjcvp/pvab025. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35512362
The heart in Anderson Fabry disease.
Kampmann C, Wiethoff CM, Perrot A, Beck M, Dietz R, Osterziel KJ. Kampmann C, et al. Z Kardiol. 2002 Oct;91(10):786-95. doi: 10.1007/s00392-002-0848-5. Z Kardiol. 2002. PMID: 12395219 Review.
International guidelines for the management and treatment of Morquio A syndrome.
Hendriksz CJ, Berger KI, Giugliani R, Harmatz P, Kampmann C, Mackenzie WG, Raiman J, Villarreal MS, Savarirayan R. Hendriksz CJ, et al. Among authors: kampmann c. Am J Med Genet A. 2015 Jan;167A(1):11-25. doi: 10.1002/ajmg.a.36833. Epub 2014 Oct 24. Am J Med Genet A. 2015. PMID: 25346323 Free PMC article. Review.
Enzyme replacement therapy and the heart.
Kampmann C. Kampmann C. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 37. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 37. PMID: 21290687 Free Books & Documents. Review.
83 results